Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Neurology|August 28, 2002
Increased CSF hypocretin-1 (orexin-A) in restless legs syndromeR P Allen, E Mignot, B Ripley, et al.Psychiatry and Clinical Neurosciences|June 26, 2001
Narcoleptic canines display periodic leg movements during sleepM Okura, N Fujiki, B Ripley, et al.Peptides|May 17, 2005
CSF hypocretin-1/orexin-A concentrations in patients with subarachnoid hemorrhage (SAH)K Dohi, B Ripley, N Fujiki, et al.International Journal of Clinical Pharmacology and Therapeutics|January 1, 1994
The effect of nonsteroidal agents (NSAIDs) on the pharmacokinetics and pharmacodynamics of metolazoneE B Ripley, T W Gehr, H Wallace, et al.The European Journal of Neuroscience|October 31, 2001
Fluctuation of extracellular hypocretin-1 (orexin A) levels in the rat in relation to the light-dark cycle and sleep-wake activitiesY Yoshida, N Fujiki, T Nakajima, et al.Neuroscience Letters|October 30, 2001
Decreased brain histamine content in hypocretin/orexin receptor-2 mutated narcoleptic dogsS Nishino, N Fujiki, B Ripley, et al.Annals of Neurology|September 18, 2001
Low cerebrospinal fluid hypocretin (Orexin) and altered energy homeostasis in human narcolepsyS Nishino, B Ripley, S Overeem, et al.Neurology|September 25, 2003
CSF hypocretin levels in Guillain-Barré syndrome and other inflammatory neuropathiesS Nishino, T Kanbayashi, N Fujiki, et al.Neurology|January 5, 2002
CSF hypocretin/orexin levels in narcolepsy and other neurological conditionsB Ripley, S Overeem, N Fujiki, et al.Nature Medicine|September 6, 2000
A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brainsC Peyron, J Faraco, W Rogers, et al.Pageof 2